P de Miranda

6.9k citations
68 papers · 5.5k indexed · 2 hit papers · h-index 35

Impact in

  • Virology top 1%
    • HIV Research and Treatment
  • Epidemiology top 0.5%
    • Herpesvirus Infections and Treatments
    • Cytomegalovirus and herpesvirus research

Papers in

    • HIV Research and Treatment 7
    • Herpesvirus Infections and Treatments 44
    • Cytomegalovirus and herpesvirus research 24

P de Miranda

68 papers receiving 5.0k citations

Hit Papers

9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group 1978 · 935 citations
93519772026199320094008001.2k

Peers

P de Miranda
Comparison fields: 5 of 122
  • Virology 482
  • Epidemiology 3.5k
  • Infectious Diseases 1.3k
  • Hepatology 304
  • Oncology 925
Replace Gertrude B. Elion with:
Gertrude B. Elion United States
James A. Fyfe United States
Lilia M. Beauchamp United States
Phillip A. Furman United States
Lieve Naesens Belgium
Christopher McGuigan United Kingdom
John C. Drach United States
M H St Clair United States
Mark N. Prichard United States
Howard J. Schaeffer United States
P de Miranda relative to Gertrude B. Elion United States Gertrude B. Elion's profile →
Citations per field
00.5×1.5×
Gertrude B. Elion · 1×
Citations per year

Countries citing papers authored by P de Miranda

Since Specialization
Citations

This map shows the geographic impact of P de Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P de Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P de Miranda more than expected).

Fields of papers citing papers by P de Miranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P de Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P de Miranda. The network helps show where P de Miranda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P de Miranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P de Miranda Line = papers co-authored together P de Miranda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 199613
2 199538
3 19944
4 1993313
5 199338
6 199212
7 199214
8 199057
9 199040
10 198995
11 198898
12 198810
13 198829
14 198638
15 198625
16 198320
17 1982167
18 198197
19 19759
20 197345

About P de Miranda

P de Miranda is a scholar working on Virology, Epidemiology, Immunology, Pharmacology and Ophthalmology, having authored 68 papers that have together received 5.5k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (44 papers), Cytomegalovirus and herpesvirus research (24 papers), HIV/AIDS drug development and treatment (12 papers), Toxin Mechanisms and Immunotoxins (11 papers), Virus-based gene therapy research (8 papers), HIV Research and Treatment (7 papers), Biochemical and Molecular Research (6 papers) and Viral-associated cancers and disorders (6 papers). The work is most often cited by research in Virology (482 citations), Epidemiology (3.5k citations), Infectious Diseases (1.3k citations), Hepatology (304 citations) and Oncology (925 citations). P de Miranda has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Gertrude B. Elion, Lilia M. Beauchamp, Martin Blum, Phillip A. Furman, James A. Fyfe, Howard J. Schaeffer, H. J. Schaeffer, Steven S. Good, Peter Collins and D. J. Bauer. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The American Journal of Medicine, Toxicological Sciences, Journal of Pharmacology and Experimental Therapeutics and Antiviral chemistry & chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026